El uso de glucocorticoides en la artritis reumatoide temprana

The recently introduced term of window of opportunity in the management of early rheumatoid arthritis (RA) lead us to review the effective and aggressive use of traditional therapies very early in the disease, following published evidence. The corticoids have been used for years, always with controversy, both because their role in the symptom management of RA and the limitations caused by their toxicity. This paper revises the medical literature in the field of early RA and attempts to clarify the evidence behind the use of corticosteroids in clinical practice and to suggest a guideline in the early stages of the disease.